Advanced search
1 file | 2.75 MB

Characterisation of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

(2016) JOURNAL OF GENERAL VIROLOGY. 97(8). p.1865-1876
Author
Organization
Abstract
An effective immune response against HCV requires the early development of multi-specific class 1 CD8+ and class II CD4+ T cell together with broad neutralizing antibody (NAb) responses. We have produced mammalian cell-derived HCV VLPs incorporating core, E1 and E2 of HCV genotype 1a to produce such immune responses. Here we decribe the biochemical and morphological characterisation of the HCV VLPs and study HCV core specific T cell responses to the particles. The E1 and E2 glycoproteins in HCV VLPs formed non-covalent heterodimers and together with core protein assembled into VLPs with a buoyant density of 1.22 to 1.28 g/cm3. The HCV VLPs could be immunoprecipited with anti-ApoE and anti-ApoC. On electron microscopy the VLPs had a heterogeneous morphology and ranged in size from 40 to 80nm. The HCV VLPs demonstrated dose-dependent binding to murine-derived dendritic cells and the entry of HCV VLPs into Huh7 cells was blocked by anti-CD81 antibody. Vaccination of BALB/c mice with HCV VLPs purified from iodixanol gradients resulted in the production of neutralising antibody responses while vaccination of humanized MHC class I transgenic mice resulted in the prodution of HCV core specific CD8+ T cell responses. Furthermore, IgG purified from the sera of patients chronically infected with HCV genotypes 1a and 3a blocked the binding and entry of the HCV VLPs into Huh7 cells. These results show that our mammalian cell-derived-HCV VLPs induce humoral and HCV specific CD8+ T cell responses and will have important implications for the development of a preventative vaccine for HCV.
Keywords
BROADLY NEUTRALIZING ANTIBODIES, HUMAN MONOCLONAL-ANTIBODIES, ENVELOPE GLYCOPROTEINS, IMMUNE-RESPONSES, E2 GLYCOPROTEIN, IN-VITRO, INFECTION, CLEARANCE, HCV, IMMUNIZATION

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.75 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Earnest-Silveira, L, B Chua, R Chin, D Christiansen, D Johnson, S Herrmann, SA Ralph, et al. 2016. “Characterisation of a Hepatitis C Virus-like Particle Vaccine Produced in a Human Hepatocyte-derived Cell Line.” Journal of General Virology 97 (8): 1865–1876.
APA
Earnest-Silveira, L., Chua, B., Chin, R., Christiansen, D., Johnson, D., Herrmann, S., Ralph, S., et al. (2016). Characterisation of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line. JOURNAL OF GENERAL VIROLOGY, 97(8), 1865–1876.
Vancouver
1.
Earnest-Silveira L, Chua B, Chin R, Christiansen D, Johnson D, Herrmann S, et al. Characterisation of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line. JOURNAL OF GENERAL VIROLOGY. 2016;97(8):1865–76.
MLA
Earnest-Silveira, L, B Chua, R Chin, et al. “Characterisation of a Hepatitis C Virus-like Particle Vaccine Produced in a Human Hepatocyte-derived Cell Line.” JOURNAL OF GENERAL VIROLOGY 97.8 (2016): 1865–1876. Print.
@article{8055268,
  abstract     = {An effective immune response against HCV requires the early development of multi-specific class 1 CD8+ and class II CD4+ T cell together with broad neutralizing antibody (NAb) responses. We have produced mammalian cell-derived HCV VLPs incorporating core, E1 and E2 of HCV genotype 1a to produce such immune responses. Here we decribe the biochemical and morphological characterisation of the HCV VLPs and study HCV core specific T cell responses to the particles. The E1 and E2 glycoproteins in HCV VLPs formed non-covalent heterodimers and together with core protein assembled into VLPs with a buoyant density of 1.22 to 1.28 g/cm3. The HCV VLPs could be immunoprecipited with anti-ApoE and anti-ApoC. On electron microscopy the VLPs had a heterogeneous morphology and ranged in size from 40 to 80nm. The HCV VLPs demonstrated dose-dependent binding to murine-derived dendritic cells and the entry of HCV VLPs into Huh7 cells was blocked by anti-CD81 antibody. Vaccination of BALB/c mice with HCV VLPs purified from iodixanol gradients resulted in the production of neutralising antibody responses while vaccination of humanized MHC class I transgenic mice resulted in the prodution of HCV core specific CD8+ T cell responses. Furthermore, IgG purified from the sera of patients chronically infected with HCV genotypes 1a and 3a blocked the binding and entry of the HCV VLPs into Huh7 cells. These results show that our mammalian cell-derived-HCV VLPs induce humoral and HCV specific CD8+ T cell responses and will have important implications for the development of a preventative vaccine for HCV.},
  author       = {Earnest-Silveira, L and Chua, B and Chin, R and Christiansen, D and Johnson, D and Herrmann, S and Ralph, SA and Vercauteren, Koen and Mesalam, Ahmed Atef Ahmed Abouzeid and Meuleman, Philip and Das, S and Boo, I and Drummer, H and Bock, C-T and Gowans, EJ and Jackson, DC and Torresi, Joseph },
  issn         = {0022-1317},
  journal      = {JOURNAL OF GENERAL VIROLOGY},
  language     = {eng},
  number       = {8},
  pages        = {1865--1876},
  title        = {Characterisation of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line},
  url          = {http://dx.doi.org/10.1099/jgv.0.000493},
  volume       = {97},
  year         = {2016},
}

Altmetric
View in Altmetric
Web of Science
Times cited: